Skip to main content
Caplight Logo









Endomatic Ltd.

Endomatic Ltd.

Private
Or YehudaHealthcare & Life Scienceshttps://endomaticmed.com

Last Round

Seed

Aug 1, 2025

Company Overview

Endomatic Ltd. operates in Healthcare & Life Sciences and is based in Or Yehuda. Its latest recorded funding round was a Seed round in August 2025.

Endomatic Ltd. is a medical device company that develops endovascular Left Atrial Appendage (LAA) closure devices designed to prevent strokes in patients with atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Endomatic Ltd. Comparables

Compare Endomatic Ltd. with similar companies based on industry and business-model similarity.

Endomatic Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Append Medical
91%
AuriGen Medical
88%
Parasol Med Tech, Inc.
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Endomatic Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2025
VC RoundSep 1, 2024
VC RoundMar 1, 2024
VC RoundJan 1, 2023
SeedDec 31, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Endomatic Ltd. Investors

Notable investors and investment history

Endomatic Ltd. investors
InvestorRounds
Peregrine VenturesVC Round, Seed
Incentive IncubatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2025

    Seed round led by Peregrine Ventures.

  • Sep 1, 2024

    VC Round led by Peregrine Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Endomatic Ltd. Filings

Explore SEC and related filing metadata, where available.

Endomatic Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Endomatic Ltd.'s valuation, stock price, and market status.

Is Endomatic Ltd. a public or private company?

Endomatic Ltd. is a private company.

What is the current stock price of Endomatic Ltd.?

Endomatic Ltd. is a private company, so its shares have no public market price. Caplight tracks Endomatic Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Endomatic Ltd. worth (valuation)?

Valuation information for Endomatic Ltd. is not publicly available.

Can I buy Endomatic Ltd. stock?

Endomatic Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Endomatic Ltd.'s last funding round?

Endomatic Ltd.'s most recent funding round was Seed on August 1, 2025.

Who are the main investors in Endomatic Ltd.?

Key investors in Endomatic Ltd. include Peregrine Ventures.

Will Endomatic Ltd. IPO soon?

No public IPO plans have been announced for Endomatic Ltd..

How can I track Endomatic Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Endomatic Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersOr Yehuda
Year Founded2018
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?